Despite inducing weight reduction, GLP-1 RAs preserved the hemodynamic advantages of obesity by mitigating related comorbidities like hypertension and diabetes without compromising survival benefits. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.